According to IMARC Group’s latest report, titled “Virus Filtration Market: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” the global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027.
Report Metric
Historical: 2016-2021
Base Year: 2021
Forecast Year: 2022-2027
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Virus filtration refers to a robust and effective virus clearance technology used in the manufacturing of biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within the pores of the membrane from biotech and plasma processes. It provides a critical defense mechanism against the introduction of adventitious viruses into a different class of medicines.
Request Free Sample Report: https://www.imarcgroup.com/virus-filtration-market/requestsample
Market Trends
Biological therapeutic products are generally produced using mammalian cell lines or human plasma, which increases the risk of contamination. This, in confluence with the rising need for therapeutic products on account of the growing prevalence of chronic diseases, represents one of the key factors driving the demand for virus filtration solutions across the globe. Apart from this, governing agencies of numerous countries are implementing stringent regulations to ensure the virological safety of biological therapeutics. This is encouraging pharmaceutical manufacturers to integrate virus filtration methods to evaluate and mitigate the risks of virus contamination.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/virus-filtration-market
List of Key Companies Covered in this Market Report:
Asahi Kasei Medical Co. Ltd.
Charles River Laboratories, Inc (NYSE: CRL)
Clean Cells
Danaher Corporation (NYSE: DHR)
Merck KGaA (ETR: MRK)
Sartorius AG (ETR: SRT)
Thermo Fisher Scientific Inc.(NYSE: TMO)
The report has segmented the market on the basis of product, application, end use and geography.
Breakup by Product:
Consumables
Kits and Reagents
Others
Instruments
Filtration Systems
Chromatography Systems
Services
Breakup by Application:
Biologicals
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Others
Medical Devices
Water Purification
Air Purification
Others
Breakup by End Use:
Biopharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Others
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Follow us on Twitter: https://twitter.com/ImarcServices
